The global vaginal rejuvenation market size was valued at USD 1.8 billion in 2023 and is projected to reach a value of USD 5.0 billion by 2032, registering a CAGR of 11.7% during the forecast period (2024-2032). Changing women's lifestyles and increased knowledge of related therapy or surgery are likely to drive vaginal rejuvenation market share during the forecast period.
Vaginal rejuvenation is a broad phrase that refers to a variety of medical and cosmetic procedures designed to improve the appearance, function, and overall health of the vagina. These operations are intended to address a variety of concerns with vaginal laxity, dryness, and other disorders that may emerge as a result of aging, childbirth, hormonal changes, or certain medical conditions.
The growing popularity of vaginal rejuvenation surgery is fueling the market owing to an increasing number of treatment options, rising demand, research studies, and associated debates. Furthermore, non-invasive methods like laser and radiofrequency treatments drive market expansion. The introduction of fractional carbon dioxide (CO2) lasers has gained popularity, particularly among vulvovaginal atrophy (VVA) patients, due to their non-invasive nature, short downtime, and excellent results. However, the market confronts several hurdles, including the societal stigma associated with gynecological therapies and tight regulations for energy-based gynecological operations.
The global demographic change to an aging population has raised the demand for healthcare and aesthetic remedies, such as vaginal rejuvenation. In 2000, 11% of the world's female population was 60 or older. By 2025, the world will have 604 million older women, with 70% residing in poor countries and 70% in rural regions. Aging can cause physiological changes in vaginal tissues, such as decreased collagen production and elasticity, which contribute to difficulties, including vaginal laxity and dryness.
Additionally, lifestyle variables such as delivery and hormone swings might have an impact on vaginal health. The aging population provides a considerable market opportunity for vaginal rejuvenation operations. Women in this group may seek treatment for issues such as vaginal atrophy, urine incontinence, and decreased sexual function. Healthcare practitioners and cosmetic clinics are reacting to this need by providing a variety of operations tailored to the unique needs of older people.
Furthermore, a study found that women aged 27 to 45 had more frequent and vivid sexual fantasies than younger or older women. They also had more sex and were more likely to have it early in their relationship. As a result, the impact of aging on demand for vaginal rejuvenation varies by country, depending on cultural factors, healthcare infrastructure, and public attitudes toward aging. Developed regions with a higher population of senior people may see a greater demand for these operations.
Regulatory monitoring has increased in response to concerns about the safety, marketing methods, and efficacy claims of specific vaginal rejuvenation devices and procedures. The United States Food and Drug Administration (FDA) and other regulatory agencies have taken steps to address potential dangers and protect patients. In 2018, the US Food and Drug Administration (FDA) issued a public warning on the use of energy-based vaginal rejuvenation devices. The FDA warned that energy-based vaginal rejuvenation devices can be dangerous and should be avoided. The FDA concerns deceptive marketing, unidentified dangers, and unproven efficacy.
Furthermore, in a safety communication, the FDA also stated that there is insufficient evidence to support the safety and effectiveness of energy-based devices for vaginal rejuvenation. The statement emphasized potential hazards like burns, scars, and pain and recommended that healthcare providers set realistic patient expectations. The FDA continues to evaluate the safety of vaginal rejuvenation procedures via post-market surveillance. This continuing oversight aims to identify and treat adverse occurrences while ensuring manufacturers and practitioners follow regulatory criteria. According to a 2023 CMAJ article, laser technologies for vaginal rejuvenation are safe, regulated, and marketed. Many innovative medical devices, including vaginal energy devices, do not require controlled trials for regulatory approval. Some case studies indicate that vaginal energy devices may be helpful for GSM or incontinence.
The growing demand for nonsurgical and minimally invasive therapies represents a significant opportunity for the vaginal rejuvenation market. Patients are increasingly looking for procedures that produce effective results with less downtime and lower dangers than standard surgical methods. Nonsurgical techniques such as laser therapy (e.g., fractional CO2 or erbium laser treatments) and radiofrequency treatments are becoming more popular. These procedures increase collagen formation in the vaginal tissues, which addresses issues including laxity and dryness. According to a 2023 article in BMC Women's Health, vaginal laser treatment can increase the prevalence of lactobacilli in postmenopausal women by 30% to 79%.
In addition, nonsurgical methods appeal to a larger demographic, including those who are hesitant or ineligible for surgery. These procedures are appealing because they are convenient, cause slight discomfort, and have shorter recovery times. Consumer surveys and market research show that people seeking aesthetic and wellness treatments choose nonsurgical options. Patients frequently favor therapies that fit their hectic schedules and produce natural-looking results.
Moreover, rising demand for energy-based treatments is expected to drive the vaginal rejuvenation market in the coming years. Energy-based devices for targeted surgery use thermal or non-thermal energy to distinct layers of vaginal tissue. This increases collagen regeneration, strengthens elastic fibers, promotes neovascularization, and restores vaginal lubrication. The business opportunity is catering to patients' evolving preferences for nonsurgical procedures. Companies specializing in non-invasive technology and procedures are ideally positioned to benefit from this expanding demand.
| Study Period | 2020-2032 | CAGR | 11.7% |
| Historical Period | 2020-2022 | Forecast Period | 2024-2032 |
| Base Year | 2023 | Base Year Market Size | USD 1.8 billion |
| Forecast Year | 2032 | Forecast Year Market Size | USD 5.0 billion |
| Largest Market | North America | Fastest Growing Market | Asia Pacific |
The global vaginal rejuvenation market analysis is conducted in North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.
North America is the most significant global vaginal rejuvenation market shareholder and is estimated to grow at a CAGR of 11.8% over the forecast period. The United States is likely to create substantial money at the national level. The solid regional market can be attributable to the growing popularity of vaginal operations such as clitoral hood reduction, monsplasty, vaginoplasty, and Labiaplasty. According to a survey performed by the American Society of Plastic Surgeons, the number of vaginal rejuvenation treatments has increased by more than 30% in the United States alone. The introduction of new creative non-invasive vaginal surgery treatments that deliver the desired outcomes with fewer side effects and complications is also driving the U.S. vaginal rejuvenation market forward. Furthermore, according to a 2023 NCBI article, vaginoplasty is one of the most commonly performed genital reconstructive procedures in the United States, accounting for 7% of gender-affirming surgeries.
In addition, the existence of significant market participants in the United States and Canada, rising disposable income, greater demand for improving overall genital attractiveness, and lifestyle changes are driving the growth of North America's vaginal rejuvenation industry. The prevalence of pelvic floor problems such as urine incontinence and pelvic organ prolapse is driving market expansion since these conditions can be treated with vaginal rejuvenation treatment. According to the National Institutes of Health, over 24% of women in the United States suffer from pelvic floor diseases, which include pelvic organ prolapse (POP). The number of people who require surgery is predicted to climb by 47% over the next few decades. According to research published in June 2022, around one-quarter of American women suffer from pelvic floor disorder. The prevalence of pelvic floor illnesses among women over the age of 80 has more than doubled. As a result, the high prevalence of pelvic floor diseases may spur interest in vaginal rejuvenation operations, fueling market growth.
Asia-Pacific is anticipated to exhibit a CAGR of 12.4% over the forecast period owing to the increased use of improved technologies as well as an increase in marketing and commercialization of vaginal rejuvenation treatments. Increased occurrences of pelvic floor problems are projected to drive demand for this market. According to ABC News, more than 5 million Australians over the age of 15 will suffer from urine incontinence by 2023. This represents around one in every four people, 10% of males and 38% of women. By 2030, the number is predicted to reach 6.5 million. The rise in knowledge of the availability of vaginal rejuvenation treatment among healthcare professionals and women, medical tourism, and an increase in healthcare expenditure are expected to drive market expansion during the forecast period.
Furthermore, according to World Economic Forum (2023) forecasts, the APAC region's GDP climbed from USD 15,133.08 billion to a predicted GDP of 30,280.20 billion by 2024, accounting for almost 60% of global GDP growth by 2030. The increase in GDP reflects the region's expanding disposable income, boosting customer spending power on various items and services, including healthcare services. Rising disposable incomes have primarily driven the region's increased demand for cosmetic and restorative services. The popularity of energy-based vaginal rejuvenation systems has grown as the number of cosmetic genital operations has increased steadily. As a result, the region's increasing financial prosperity is likely to boost demand for cosmetic operations, which in turn is expected to contribute to the demand for vaginal rejuvenation systems, propelling the Asia-Pacific vaginal rejuvenation systems market.
Europe holds a significant market share. Germany dominated the European market because of a growing number of surgeons and increased awareness of vaginal laxity treatment options. The increased commercialization and marketing of vaginal rejuvenation treatments in the country is driving the market expansion. For instance, according to a 2023 survey, Switzerland has the most significant number of persons who identify as transgender, non-binary or gender-fluid out of 30 countries. In the study, around 6% of respondents in Switzerland identified as one of the listed genders. As a result, transgender people may undergo vaginoplasty, which will drive the industry in the region.
The Middle East and Africa (MEA) are likely to increase at a constant rate because there is little awareness of vaginal rebuilding treatments, and body augmentation is limited to the face and a few other places. Furthermore, the cost of these operations is considerable, restricting the expansion of the vaginal rejuvenation market in these regions.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global vaginal rejuvenation market is segmented based on type.
The market is further segmented by type into Reconstructive Vaginal Rejuvenation, Cosmetic Vaginal Rejuvenation.
The cosmetic vaginal rejuvenation sector maintained the most significant market share at 70%. Cosmetic vaginal rejuvenation focuses on improving the aesthetic appearance of the genital area while also addressing concerns about the exterior appearance of the vagina. This category encompasses surgical and nonsurgical procedures to improve the vulva's visual symmetry, shape, and general look. Labiaplasty, clitoral hood reduction, and fat grafting to restore volume to the labia majora are everyday cosmetic vaginal rejuvenation operations. Patients who want cosmetic vaginal rejuvenation are frequently motivated by personal preferences or aesthetic considerations rather than functional issues.
G-spot amplification, labioplasty, hymenoplasty, and cordectomy are the four types of cosmetic vaginal rejuvenation procedures. Cosmetic vaginal rejuvenation accounted for a more significant share of the market in 2023, owing to rising demand for operations such as vaginoplasty, monsplasty, clitoral hood reduction, and Labiaplasty. Labiaplasty is the most regularly done operation due to the growing incidence of genital disorders, . The popularity of Labiaplasty has increased by 53% in the last five years, according to the American Society for Aesthetic Plastic Surgery (ASAPS). In 2021, 18,813 labiaplasty treatments were recorded in the United States, a 36% increase over 2020. According to ASAPS, labiaplasties will increase by 53% in the next five years.
Perineoplasty and vaginoplasty are two sub-categories of reconstructive vaginal rejuvenation. Reconstructive vaginal rejuvenation refers to surgical or nonsurgical techniques that aim to correct functional concerns and restore vaginal anatomy. Women who have had alterations in their vaginal health as a result of childbirth, trauma, or medical issues frequently seek this form of rejuvenation. Vaginoplasty, which tightens and repairs the vaginal canal, perineoplasty, which improves the perineal area, and Labiaplasty, which addresses asymmetry or discomfort, are all possible procedures. Reconstructive vaginal rejuvenation attempts to increase pelvic floor support, relieve physical pain, and improve overall vaginal function. The methods are frequently adapted to each patient's anatomical and functional demands, providing physical well-being and a higher quality of life.
The reconstructive vaginal rejuvenation segment is expected to develop significantly throughout the forecast period as a result of an increasing number of patients experiencing prolapse progression, decreased vaginal sensation due to vaginal wall laxity, and sexual dysfunction. Reconstructive vaginal rejuvenation focuses on mending and straightening the vaginal structure, particularly following a C-section. This allows women to continue their lives without experiencing issues or pain during urination, intercourse, or menstruation.
The COVID-19 pandemic has posed a severe threat to the global food system by disrupting its long supply chains and logistics. A diverse local agriculture network can help urban areas create a more resilient food system for its residents. Furthermore, the pandemic has impacted markets and farm prices, supply chain slowdowns and shortages, farmers' health, farm workforce, and worker safety, among other disruptions. The farming sector has witnessed a sharp dip in the business, including the dealership network, and the reluctance of farmers to purchase expensive high-powered farm equipment in light of the pandemic.
The governments are slowly lifting lockdowns after months of restrictions, which is anticipated to bring the farm equipment market opportunities to grow. The opening of manufacturing facilities, international borders, and favorable monsoon conditions in equatorial regions are expected to restore the global agriculture and farming industry. Government initiatives and support to farmers are also expected to encourage the farmer's morale. The U.S. government announced a USD 19 billion relief program to farmers, including USD 16 billion in direct payments to producers this year.
